Theraflu Extra Lemon 650mg+10mg+20mg powder for oral solution with lemon flavour

Страна: Вірменія

мова: англійська

Джерело: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активний інгредієнт:

paracetamol, phenylephrine (phenylephrine hydrochloride), pheniramine (pheniramine maleate)

Доступна з:

Famar Orleans

Код атс:

N02BE51

ІПН (Міжнародна Ім'я):

paracetamol, phenylephrine (phenylephrine hydrochloride), pheniramine (pheniramine maleate)

Дозування:

650mg+10mg+20mg

Фармацевтична форма:

powder for oral solution with lemon flavour

Одиниць в упаковці:

(10) sachets 15g

Тип рецепту:

OTC

Статус Авторизація:

Registered

Дата Авторизація:

2019-06-05

Характеристики продукта

N O V A R T I S
Global Drug Regulatory Affairs
THERAFLU EXTRA LEMON
Powder in Sachets
Actives substances
Paracetamol 650mg; Pheniramine maleate 20mg;
Phenylephrine hydrochloride 10mg;
SUMMARY OF PRODUCT CHARACTERISTICS
Property of Novartis Consumer Health
SA Confidential
May not be used, divulged, published or otherwise
disclosed without the consent of Novartis Consumer Health
SA
TABLE OF CONTENTS
1.
NAME OF THE MEDICINAL PRODUCT
.........................................................................
3
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
.............................................. 3
3.
PHARMACEUTICAL FORM
..............................................................................................
3
4.
CLINICAL PARTICULARS
.................................................................................................
3
4.1 THERAPEUTIC INDICATIONS
................................................................................................
3
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
................................................................... 3
4.3.
CONTRAINDICATIONS
.......................................................................................................
3
4.4.
SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE
.................................................... 4
4.5.
INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION ......... 4
4.6.
PREGNANCY AND LACTATION
.............................................................................................
5
4.7.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
............................................................ 5
4.8.
UNDESIRABLE EFFECTS
.......................................................................................................6
4.9.
OVERDOSE
.......................................................................................................................
6
5.
PHARMACOLOGICAL PROPERTIES
..............................................................................
7
5.1.
PHARMACODYNA